医薬品グレード炭酸リチウムの世界市場：2023-2030年

世界の医薬品グレード炭酸リチウム（Li2CO3）市場は、予測期間中に4.8%というかなりのCAGRで成長すると予測されています。医薬品グレードの炭酸リチウムは、双極性障害やうつ病などの気分障害の治療に使用される薬剤です。精神障害の有病率の高さは、世界の医薬品グレード炭酸リチウム市場の成長を促進する主な要因です。双極性障害の世界の蔓延は一定数増加すると推定され、男性よりも女性に多いです。世界保健機関（WHO）が発表した報告書によると、2022年6月、2019年には4,000万人が双極性障害を経験しています。米国NCBIの論文によると、2020年、12歳以上の米国人の9.2％（SE=0.31）が過去1年間に大うつ病エピソードを経験しています。うつ病は18～25歳の若年成人（17.2％、SE=0.78）に多く、次いで12～17歳の青年（16.9％、SE=0.84）が僅差で続いています。うつ病は青年と若年成人において最も急速に増加し、ほぼすべての性、人種/民族、所得、教育群において増加しました。35歳以上の成人ではうつ病有病率は変化せず、助けを求める人々の有病率は調査期間を通じて一貫して低いままでした。

精神障害の有病率の高さと、その治療のための炭酸リチウムの分野における調査の増加は、医薬品グレード炭酸リチウム市場の成長に寄与する主な要因です。

セグメント別展望

純度99.0%セグメントが世界市場で主要シェアを占める

2022年の医薬品グレードリチウム市場で主要な市場シェアを占めたセグメントは純度99%セグメントでした。純度99%の高品位炭酸リチウムは医薬品製剤に広く使用されています。この純度レベルは、有効成分（リチウム）が医薬品グレードであり、患者の安全を脅かす汚染物質がないことを保証します。

地域別展望

医薬品グレード炭酸リチウムの世界市場は、北米（米国とカナダ）、欧州（イタリア、スペイン、ドイツ、フランス、その他）、アジア太平洋（インド、中国、日本、韓国、その他）、世界のその他の地域（中東とアフリカ、ラテンアメリカ）など、地域によってさらに細分化されます。中でも北米が最大の市場シェアを占めています。精神障害に対する人々の意識が高く、治療薬が入手可能であることが、この地域市場の成長を促進する主な要因です。

アジア太平洋地域は医薬品グレード炭酸リチウムの世界市場において著しいCAGRで成長する見込み

アジア太平洋地域は、世界の医薬品グレード炭酸リチウム市場において急速なペースで拡大すると予測されています。中国、インド、日本などの新興国における製薬産業の成長が市場成長の主な要因です。この地域における気分障害の有病率の上昇とメンタルヘルス問題に対する意識の高まりが、医薬品グレード炭酸リチウムの需要を促進する可能性があります。

目次

第1章 レポート概要

• 業界の現状分析と成長可能性の展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Albemarle Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• American Elements
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
  • Privacy Policy
• Globe Quimica
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Jiangsu Nhwa Pharmaceutical Co., Ltd
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Livent Corp.
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向

第4章 市場セグメンテーション

• 世界の医薬品グレード炭酸リチウム市場：純度別
  • 99%
  • 99%以上
• 世界の医薬品グレード炭酸リチウム市場：用途別
  • 徐放性
  • 即時放出性
• 世界の医薬品グレード炭酸リチウム市場：エンドユーザー別
  • 病院
  • 診療所
  • 小売薬局

第5章 地域分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域

第6章 企業プロファイル

• American Lithium Corp.
• Chemetall
• FMC Corp.
• Galaxy Resources Ltd.
• Ganfeng Lithium Co., Ltd.
• Green Technology Metals
• International Lithium Corp.
• Lake Resources NL
• Liontown Resources Ltd.
• Lithium Americas Corp.
• Lithium Australia
• Lithium Chile
• Nemaska Lithium
• Pilbara Minerals Ltd.
• Sayona Mining Ltd.
• Sigma Lithium
• SQM
• Tianqi Lithium Industry Co., Ltd.

LIST OF TABLES

• 1. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY PURITY, 2022-2030 ($ MILLION)
• 2. GLOBAL 99.0% PURE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
• 3. GLOBAL ABOVE 99% PURE PHARMACEUTICALS GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 5. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR EXTENDED-RELEASE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 6. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR IMMEDIATE-RELEASE MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 7. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 8. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR HOSPITALS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 9. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR CLINICS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 10. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR RETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
• 11. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. NORTH AMERICAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 13. NORTH AMERICAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY PURITY, 2022-2030 ($ MILLION)
• 14. NORTH AMERICAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 15. NORTH AMERICAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 16. EUROPEAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 17. EUROPEAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY PURITY, 2022-2030 ($ MILLION)
• 18. EUROPEAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 19. EUROPEAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 20. ASIA-PACIFICPHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 21. ASIA-PACIFICPHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY PURITY, 2022-2030 ($ MILLION)
• 22. ASIA-PACIFICPHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 23. ASIA-PACIFIC PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
• 24. REST OF THE WORLD PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 25. REST OF THE WORLD PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY PURITY, 2022-2030 ($ MILLION)
• 26. REST OF THE WORLD PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 27. REST OF THE WORLD PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATEMARKET SHARE BY PURITY, 2022 VS. 2030 (%)
• 2. GLOBAL 99.0% PURE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE BY REGION, 2022 VS. 2030 (%)
• 3. GLOBAL ABOVE 99.0% PURE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE BY APPLICATION, 2022 VS. 2030 ($ MILLION)
• 5. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR EXTENDED-RELEASE MARKET SHARE BY REGION, 2022 VS. 2030 (%)
• 6. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR IMMEDIATE-RELEASE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE BY END-USER, 2022 VS 2030 ($ MILLION)
• 8. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE FOR RETAIL PHARMACY MARKETSHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. US PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 13. CANADA PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 14. UK PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 15. FRANCE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 16. GERMANY PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 17. ITALY PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 18. SPAIN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 19. REST OF EUROPE PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 20. INDIA PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 21. CHINA PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 22. JAPAN PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 23. SOUTH KOREA PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 24. REST OF ASIA-PACIFIC PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)
• 25. REST OF THE WORLD PHARMACEUTICAL GRADE LITHIUM CARBONATE MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Pharmaceutical Grade Lithium Carbonate Market Size, Share & Trends Analysis Report Market by Purity (99%, above 99%), by Application (Extended release, Immediate Release), and by End-User (Hospitals, Clinics, and Retail Pharmacies)Forecast Period (2023-2030).

The global pharmaceutical grade lithium carbonate (Li2CO3) market is anticipated to grow at a considerable CAGR of 4.8% during the forecast period. Pharmaceutical-grade lithium carbonate is a drug used to treat mood disorders such as bipolar disorder and depression. The high prevalence of mental disorders is a key factor driving the growth of the global pharmaceutical grade lithium carbonate market. The global widespread of bipolar disorder is estimated to rise at a certain number and it is more common in women than men. According to a report published by The World Health Organization (WHO), in June 2022, 2019, 40 million people experienced bipolar disorder. According to an article by a US organization NCBI, In 2020, 9.2% (SE=0.31) of Americans aged ≥12 years experienced a past-year major depressive episode. Depression was more common among young adults aged 18-25 years (17.2%, SE=0.78), followed closely by adolescents aged 12-17 years (16.9%, SE=0.84). Depression increased most rapidly among adolescents and young adults and increased among nearly all sex, racial/ethnic, income, and education groups. Depression prevalence did not change among adults aged ≥35 years, and the prevalence of help-seeking remained consistently low across the study period.

The high prevalence of mental disorder along with the growing research in the field of lithium carbonate for its treatment is a key factor contributing to the growth of the pharmaceutical grade lithium carbonate market.

Segmental Outlook

The global pharmaceutical grade lithium carbonate market is segmented based on purity, application, and end-user. Based on Purity, the market is segmented into 99% and above 99% .Based on application, the market is sub-segmented into extended release and immediate release. Based on end-user the market is sub-segmented into hospitals, clinics, and retail pharmacies. Based on application, the extended release segment accounted for the largest share of the global pharmaceutical grade lithium carbonate market in 2022. Medical, technological, regulatory, and market-related considerations, among others, all have an impact on the development of pharmaceutical grade lithium carbonate with extended release. Extended release formulations have a lower dose frequency, which helps patients stick to their medication schedule. People with hectic schedules or who struggle to remember to take their medications several times a day may benefit greatly from this.

The 99.0% purity segment Held a Major Market Share in the Global Market

The segment that held the major market share in the pharmaceutical-grade lithium market in 2022 was the 99% purity segment. High-grade lithium carbonate with a purity of 99% is widely used in pharmaceutical formulations. This purity level ensures that the active ingredient (lithium) is pharmaceutical grade and free of contaminants that could endanger patient safety.

Regional Outlook

The global Pharmaceutical Grade Lithium Carbonate market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, North America holds the largest market share of the market. High awareness among people about mental disorders and availability of treatment drugs is a key factor driving the growth of the regional market.

Asia-Pacific is Expected to Grow at a Significant CAGR in the Global Pharmaceutical Grade Lithium Carbonate Market

Asia Pacific is projected to expand at a rapid pace in the global pharmaceutical grade lithium carbonate market. The growing pharmaceutical industry in emerging economies such as China, India, and Japan is a key contributor to the market growth. The rising prevalence of mood disorders and increased awareness of mental health issues in this region may drive demand for pharmaceutical grade lithium carbonate.

Market Players Outlook

The major companies serving the global Pharmaceutical Grade Lithium Carbonate market include Albemarle Corp., American Elements, Globe Quimica, Jiangsu Nhwa Pharmaceutical Co., Ltd., and Livent Corp. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, and new product launches, to stay competitive in the market. For instance, In May 2023, Livent Corporation, a lithium chemicals company agreed to merge with Allkem Limited, another lithium chemicals company. The combined company, called NewCo, will be the world's largest producer of lithium carbonate and hydroxide. The merger is expected to close in the second half of 2023.The combined company will have a significant scale advantage, which will allow it to lower costs and improve profitability.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global pharmaceutical grade lithium carbonate market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Albemarle Corp.
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. American Elements
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
  • 3.3.5. Privacy Policy
• 3.4. Globe Quimica
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Jiangsu Nhwa Pharmaceutical Co., Ltd
  • 3.5.1. Overview
  • 3.5.2. Financial Analysis
  • 3.5.3. SWOT Analysis
  • 3.5.4. Recent Developments
• 3.6. Livent Corp.
  • 3.6.1. Overview
  • 3.6.2. Financial Analysis
  • 3.6.3. SWOT Analysis
  • 3.6.4. Recent Developments

4. Market Segmentation

• 4.1. Global Pharmaceutical Grade Lithium Carbonate Market by Purity
  • 4.1.1. 99%
  • 4.1.2. Above 99%
• 4.2. Global Pharmaceutical Grade Lithium Carbonate Market by Application
  • 4.2.1. Extended Release
  • 4.2.2. Immediate Release
• 4.3. Global Pharmaceutical Grade Lithium Carbonate Market by End-User
  • 4.3.1. Hospitals
  • 4.3.2. Clinics
  • 4.3.3. Retail Pharmacies

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. American Lithium Corp.
• 6.2. Chemetall
• 6.3. FMC Corp.
• 6.4. Galaxy Resources Ltd.
• 6.5. Ganfeng Lithium Co., Ltd.
• 6.6. Green Technology Metals
• 6.7. International Lithium Corp.
• 6.8. Lake Resources NL
• 6.9. Liontown Resources Ltd.
• 6.10. Lithium Americas Corp.
• 6.11. Lithium Australia
• 6.12. Lithium Chile
• 6.13. Nemaska Lithium
• 6.14. Pilbara Minerals Ltd.
• 6.15. Sayona Mining Ltd.
• 6.16. Sigma Lithium
• 6.17. SQM
• 6.18. Tianqi Lithium Industry Co., Ltd.